Coronavirus (COVID-19)

COVID-19 is a new illness and we are still learning about the impact it will have on people who use drugs. We know that the pandemic will greatly impact on the most vulnerable in society such as marginalised groups and people who have pre-existing health concerns.

We want to help people who use drugs reduce the harms as much as possible during this time. Stay safe,

You can find further information using the links below. Remember you can call the HSE Drug and Alcohol helpline on freephone 1800 459 459 or email . You can find the helpline online here and on Facebook

Drug services during COVID-19 A list of services still operating during the pandemic and their contact details.

Why people who use drugs are at risk during COVID-19 The impact of COVID-19 on people who use drugs

Harm reduction advice for people who use drugs during COVID-19 pandemic Harm reduction resources

Changes to OST Changes to Opioid Substitution Treatment during COVID-19

Overdose awareness during COVID-19 pandemic Information on overdose, including the Department of Health/HSE overdose awareness poster

Dual diagnosis Information from HSE and Dual Diagnosis Ireland on dual diagnosis and looking after your mental health during COVID-19

Naloxone Information on administering Naloxone to reverse the effect of opioid drugs in an overdose

Alcohol Information on alcohol and resources

Drug recovery Tips for remaining substance free and where to find support

Family support Links to family support resources

Domestic violence Links to information and support for people experiencing domestic violence during COVID-19

Professionals/staff Links to resources for people working with people who use drugs

General COVID-19 advice and guidelines

General advice on COVID-19 can be found on the HSE website

Partner resources including printable materials for workplaces and communities can be found here

Translated resources can be found here

A wide range of guidance documents and resources can be found on the HSE Health Protection Surveillance Centre website

Article from